Breakthrough medical innovations are transforming the way we treat and potentially cure certain diseases. There are challenges like scalability, automation, cell type flexibility, that must be solved. A critical parameter for that can affect time to market and production costs is platform selection. Also, when addressing the question of commercial viability, therapeutics developers face these crucial questions.
Join us for reviewing the platforms and processes that can go from research to production while minimizing technology transfer or re-development, that support multiple cell types and workflows including vaccines, cell and gene therapy, regenerative medicine.